The Beauty Health Company Reports Strong First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
The Beauty Health Company (SKIN) PT Lowered to $24 at Jefferies
May 11, 2022 8:25 AM EDTJefferies analyst Stephanie Wissink lowered the price target on The Beauty Health Company (NASDAQ: SKIN) to $24.00 (from $27.00) while maintaining a Buy rating following earnings.
The analyst commented, "Q1 sales +59% Y/Y driven by system sales +63% Y/Y were ahead of estimates & reflect strong... More
The Beauty Health Company (SKIN) PT Lowered to $20 at Cowen
May 11, 2022 8:04 AM EDTCowen analyst Oliver Chen lowered the price target on The Beauty Health Company (NASDAQ: SKIN) to $20.00 (from $27.00) while maintaining a Outperform rating following earnings.
The analyst commented, "We are encouraged by the early reception of Syndeo, but FY22 will be an investment... More
The Beauty Health Company (SKIN) Q1 Revenues Beats, Guides FY Revenues Higher
May 10, 2022 4:43 PM EDTThe Beauty Health Company (NASDAQ: SKIN) reported Q1 revenue of $75.4 million versus the consensus estimate of $68.37 million.
GUIDANCE:
The Beauty Health Company sees FY2022 revenue of $333-340 million, versus the consensus of $327.2 million.
For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.
... More